Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: Associations with clinicopathological parameters and patients' survival

Journal of Oral Pathology and Medicine

Volumn 40, Issue 3, 2011, Pages 218-226

  Theocharis, Stamatios ^a,b   Klijanienko, Jerzy ^a   Giaginis, Constantinos ^b   Rodriguez, Jose ^a   Jouffroy, Thomas ^a   Girod, Angelique ^a   Point, Daniel ^a   Tsourouflis, Gerasimos ^b   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clinicopathological parameters; DNA repair; Immunohistochemistry; Mobile tongue squamous cell carcinoma; Prognosis

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GLOSSECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOBILE TONGUE SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOTIC INDEX; MUTS HOMOLOG 2 PROTEIN; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROTEIN SUBUNITS; SEX FACTORS; SURVIVAL RATE; TONGUE; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 79951877583     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00945.x     Document Type: Article

References (54)

1. Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence in the United States, 1975-1988. Oral Oncol 2002; 38: 610-7.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2007; 57: 43-66.
3. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360: 1131-5.
4. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44years. Cancer 2005; 103: 1843-9.
5. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645-62.
6. Kantola S, Parikka M, Jokinen K, et al. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-9.
7. Wangsa D, Ryott M, Avall-Lundquist E, et al. Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 2008; 99: 1121-8.
8. Po Wing Yen A, Lam KY, Lam LK, et al. Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features. Head Neck 2002; 24: 513-20.
9. Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O'Brien CJ. Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg 2009; 79: 19-22.
10. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity. J Oral Maxillofac Surg 2007; 65: 229-36.
11. Friedberg EC, McDaniel LD, Schultz RA. The role of endogenous and exogenous DNA damage and mutagenesis. Curr Opin Genet Dev 2004; 14: 5-10.
12. Giaginis C, Gatzidou E, Theocharis S. DNA repair systems as targets of cadmium toxicity. Toxicol Appl Pharmacol 2006; 213: 282-90.
13. Peterson CL, Côté J. Cellular machineries for chromosomal DNA repair. Genes Dev 2004; 18: 602-16.
14. Papaefthymiou MA, Giaginis CT, Theocharis SE. DNA repair alterations in common pediatric malignancies. Med Sci Monit 2008; 14: RA8-15.
15. Nam TK, Lee JH, Cho SH, et al. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Lett 2008; 260: 109-17.
16. Zhigang H, Demin H, Han G, Erzhong F, Xiaohong C, Hongbo X. Significance and mechanism of microsatellite instability in laryngeal squamous cell carcinoma. J Otolaryngol 2007; 36: 168-74.
17. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007; 109: 703-12.
18. Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N. Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol 2006; 17: 995-9.
19. Uehara H, Miyamoto M, Kato K, et al. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J Surg Oncol 2005; 92: 109-15.
20. Tzao C, Hsu HS, Sun GH, et al. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2005; 130: 1371.
21. Nunn J, Nagini S, Risk JM, et al. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck. Oral Oncol 2003; 39: 115-29.
22. Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 2003; 105: 41-6.
23. Fujieda S, Tanaka N, Sunaga H, et al. Expression of hMSH2 correlates with in vitro chemosensitivity to CDDP cytotoxicity in oral and oropharyngeal carcinoma. Cancer Lett 1998; 132: 37-44.
24. Lo Muzio L, Nocini P, Mignogna MD, et al. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. Anticancer Res 1999; 19: 933-40.
25. Gatzidou E, Michailidi C, Tseleni-Balafouta S, Theocharis S. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Lett 2010; 290: 139-47.
26. Hsieh P. Molecular mechanisms of DNA mismatch repair. Mut Res 2001; 486: 71-87.
27. Marti TM, Kunz C, Fleck O. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 2002; 191: 28-41.
28. Haydon AM, Jass JA. Emerging pathways in colorectal cancer development. Lancet Oncol 2002; 3: 83-8.
29. Wang J, Sasco AJ, Fu C, et al. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 118-25.
30. Sawhney M, Rohatgi N, Kaur J, et al. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol 2007; 43: 515-22.
31. Rodríguez MJ, Acha A, Ruesga MT, Rodríguez C, Rivera JM, Aguirre JM. Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett 2007; 245: 263-8.
32. Liu R, Yin LH, Pu YP. Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china. J Toxicol Environ Health A 2007; 70: 956-63.
33. Kato K, Hara A, Kuno T, et al. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. Cancer Res Clin Oncol 2006; 132: 735-43.
34. Fang MZ, Jin Z, Wang Y, et al. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 2005; 26: 615-22.
35. Zhang L, Lu W, Miao X, Xing D, Tan W, Lin D. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 2003; 24: 1039-44.
36. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-74.
37. Kohya N, Miyazaki K, Matsukura S, et al. Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma. Ann Surg Oncol 2002; 9: 371-9.
38. Matsukura S, Miyazaki K, Yakushiji H, et al. Expression and prognostic significance of O6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers. Ann Surg Oncol 2001; 8: 807-16.
39. Matsukura S, Miyazaki K, Yakushiji H, Ogawa A, Chen Y, Sekiguchi M. Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma. J Surg Oncol 2003; 82: 194-200.
40. Cooper WA, Kohonen-Corish MRJ, Chan C, et al. Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions. Histopathology 2008; 52: 613-22.
41. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29: 167-78.
42. Shintani S, Matsuura H, Hasegawa Y, Nakayama B, Fujimoto Y. The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology 1997; 54: 463-7.
43. Barnes L, Eveson JW, Reichert P, Sidransky D. World Health Organization classifications tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005.
44. Po Wing Yen A, Lam KY, Wei WI, et al. A comparison of prognostic significance of tumor diameter, length, width, thickness area, volume and clinicopathological features of oral tongue carcinoma. Am J Surg 2000; 180: 139-43.
45. Michailidi C, Theocharis S, Stolakis V, Kouraklis G, Katsaronis P, Troungos C. Expression and methylation profile of DNA repair genes in Greek colon adenocarcinoma patients. Virchows Arch 2009; 455: 88.
46. Giaginis C, Daskalopoulou S, Vgenopoulou S, Sfiniadakis I, Kouraklis G, Theocharis S. Heat shock protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol 2009; 9: 14.
47. Giaginis C, Tsourouflis G, Zizi-Serbetzoglou A, et al. Clinical significance of ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 receptors in pancreatic ductal adenocarcinoma. Pathol Oncol 2010; 16: 267-76.
48. Döbrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005; 24: 9-17.
49. Tímár J, Csuka O, Remenár E, Répássy G, Kásler M. Progression of head and neck squamous cell cancer. Cancer Metastasis Rev 2005; 24: 107-27.
50. Zhang Z, Wang L, Wei S, et al. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair (Amst) 2010; 9: 558-66.
51. Puri SK, Si L, Fan CY, Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 2005; 26: 12-7.
52. Martone T, Gillio-Tos A, De Marco L, et al. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res 2007; 13: 5089-94.
53. Zuo C, Ai L, Ratliff P, et al. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 967-75.
54. Kitajima Y, Miyazaki K, Matsukura S, Tanaka M, Sekiguchi M. Loss of expression of DNA repair enzymes MGMT, hMLH1 and hMSH2 during tumor progression in gastric cancer. Gastric Cancer 2003; 6: 86-95.